You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

EVZIO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Evzio patents expire, and what generic alternatives are available?

Evzio is a drug marketed by Kaleo Inc and is included in two NDAs. There are thirty-four patents protecting this drug.

This drug has one hundred and forty-three patent family members in fifteen countries.

The generic ingredient in EVZIO is naloxone hydrochloride. There are twelve drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Evzio

A generic version of EVZIO was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EVZIO?
  • What are the global sales for EVZIO?
  • What is Average Wholesale Price for EVZIO?
Summary for EVZIO
Drug patent expirations by year for EVZIO
Drug Prices for EVZIO

See drug prices for EVZIO

US Patents and Regulatory Information for EVZIO

EVZIO is protected by thirty-three US patents.

Patents protecting EVZIO

Ultrafiltration membrane and a preparation method thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE

Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A BIOEQUIVALENT DOSE OF A NALOXONE COMPOSITION VIA A NEEDLE

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device configured to produce an audible output
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medical injector with compliance tracking and monitoring
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device having an electronic circuit system
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device having an electronic circuit system
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF AN AUTO INJECTOR TO ADMINISTER NALOXONE HCL

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD FOR CONFIRMING DOSE DELIVERY

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for EVZIO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg ⤷  Sign Up PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.